Mannin Research to Present Glaucoma Therapeutics Treatment at MedCity INVEST Chicago

Management to Present Lead drug candidate to Industry and Venture Finance Executives

NEW YORK - April 12, 2016 (Investorideas.com Newswire) Q BioMed Inc. (OTC: QBIO), a biotechnology acceleration company is pleased to announce that its license technology partner, Mannin Research, will present at MATTER Midwest University HealthTech Showcase on April 12-13th, 2016. Mannin Research will present and discuss its glaucoma treatment technology at the forum to an audience of sophisticated healthcare investors.

The showcase is part of the opening reception for the MedCity INVEST conference. MedCity INVEST (formerly the MidAmerica Healthcare Venture Forum) is a national healthcare investing conference based in Chicago. MedCity INVEST is the premier national healthcare investing conference based in the Midwest, uniting active investors with corporate business development executives to facilitate investment opportunities with promising startups. For more than a decade, biotech, medical device, digital health, diagnostics, pharma and beyond have presented there to investors like AbbVie, Qualcomm Ventures, Mayo Clinic Ventures, Baxter, Baird, Venture Investors and beyond.

Published: 13 April 2016
Written by Investor Ideas
OTCBB  
Read more: Q BioMed ( QBIO )

Files 8K; Plan to Regain NASDAQ Compliance

Company also files 8K for recent Investor Webcast Presentation

Point Roberts WA – April 12 , 2016- Investorideas.com, a digital global news source covering leading sectors including tech stocks reports that NXT-ID, Inc. (NASDAQ: NXTD), a company focused on the growing mobile commerce market, has filed an 8K addressing its NASDAQ listing and its plan to regain compliance.

Additionally the Company filed an 8K for its investor webcast held April 4th.  

Published: 13 April 2016
Written by Investor Ideas
Nasdaq  
Read more: NXT-ID Inc ( NXTD )

Nevada Energy Metals’ (TSXV: BFF.V; OTC: SSMLF; Frankfurt: A2AFBV), Advisory Board Member Malcolm Bell, Charged-up on Lithium!

Peter Epstein, CFA This email address is being protected from spambots. You need JavaScript enabled to view it. http://EpsteinResearch.com

These days, investors in emerging lithium companies seem only to care about two things. How close is a property to a producing lithium operation (or basin with high lithium concentrations)? And, how many acres (hectares) is it? Look at Clayton Valley, Nevada, home to Albemarle Corp.’s Silver Peak lithium brine operation.

Conventional wisdom says to be as close to Silver Peak as possible, wielding as many acres as possible. However, newly appointed Technical AdvisorMalcolm Bellof Nevada Energy Metals, Inc. (TSX-V: BFF)/ (OTC: SSMLF) / (Frankfurt: A2AFBV), believes there could be other Clayton Valley-like basins in the State. It’s not the zip code that counts most, but the geological setting and volcanic history.

Is it a certainty that Nevada will become a meaningful lithium suppler? No. But consider that an area of great promise for lithium-ion battery demand is the U.S. Department of Defense, (DOD). I mention it to support my view that, “security of supply” will be a crucial factor going forward. Will the DOD (indirectly) continue to rely on countries in South America and CHINA! for critical lithium-ion battery materials? 

Published: 07 April 2016
Written by Investor Ideas
Read more: Nevada Energy Metals ( BFF / SSMLF / A2AFBV )

Glaucoma Companies Aerie (Nasdaq:AERI), Glaukos (NYSE:GKOS), Q BioMed (OTCQB:QBIO), Inotek (Nasdaq:ITEK), NicOx SA (Paris: COX.PA) Approach a Devasting Disease with  a Variety of Treatments

New York, NY; Pt, Roberts, WA - April 7, 2016- Investorideas.com, a digital global news source covering leading sectors including medical technology and biotech stocks releases the following report on Glaucoma and public companies currently involved in the treatment of the disease. Glaucoma is a group of eye diseases which result in damage to the eye’s optic nerve and left untreated will lead to vision loss and eventual blindness.

US Companies currently working on Glaucoma treatments include Q BioMed Inc, (QBIO), Aerie Pharmaceuticals (AERI), Glaukos Corporation (GKOS), Inotek (ITEK).

Internationally, NicOx SA (Paris: COX.PA) and Santen Pharmaceuticals Co. Ltd. (Tokyo:4536) are leading the way with research and development and treatment options for the disease.

Read this article in full at http://www.investorideas.com/news/2016/biotech/04071.asp

Published: 07 April 2016
Written by Investor Ideas
Read more: Aerie (Nasdaq:AERI), Glaukos (NYSE:GKOS), Q BioMed (OTCQB:QBIO), Inotek (Nasdaq:ITEK), NicOx SA...

Mining in Mexico; Video Interview with President & CEO of SilverCrest Metals Inc ( TSXV: SIL.V )

Vancouver BC, Point Roberts WA – April 6, 2016- Investorideas.com, a digital global news source covering leading sectors including mining stocks issues a  video interview  with N. Eric Fier, CPG, P. Eng and President , CEO, Director of SilverCrest Metals (TSXV: SIL.V; OTC: SVCMF).
 
Eric talks about their focus on Mexico properties in both past and current ventures, SilverCrest Mines Inc and SilverCrest Metals and gives insight on why Mexico is a recipe for success for his team.  He also discusses the recent progress and updates us on the Las Chispas Project, located in Sonora, Mexico.
 
Watch Video: https://www.youtube.com/watch?v=_BZVE6jTk8I
 
Investorideas.com video channel on YouTube: https://www.youtube.com/c/Investorideas
Published: 06 April 2016
Written by Investor Ideas
Mining   TSXV  
Read more: SilverCrest Metals Inc ( SIL )
  1. Gopher Protocol Inc ( GOPH )
  2. Q BioMed Inc ( QBIO )
  3. Q BioMed Inc ( OTC: QBIO )
  4. Q BioMed Inc ( QBIO )
  5. NXT-ID ( NXTD )